Hypothesis

3 Matching Annotations

May 2026
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Randomized Phase I/II Clinical Trial of a Melanoma Helper Peptide Vaccine with or without Systemic Agonistic Anti-CD27 Antibody (Varlilumab)

1
1. scibot 06 May 2026
  
  in Public
  
  RRID:AB_2910400
  
  DOI: 10.1158/2767-9764.CRC-25-0744
  
  Resource: (BioLegend Cat# 350535, RRID:AB_2910400)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2910400
  
  What is this?
  
  RRID:AB_2910400
Visit annotations in context

Tags

RRID:AB_2910400

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC13130881/
Oct 2025
www.sciencedirect.com www.sciencedirect.com

Multi-parametric profiling of IL-7-augmented GD2.CART products in a phase 1 clinical trial

1
1. scibot 22 Oct 2025
  
  in Public
  
  RRID:AB_2910400
  
  DOI: 10.1016/j.isci.2025.113680
  
  Resource: (BioLegend Cat# 350535, RRID:AB_2910400)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2910400
  
  What is this?
  
  RRID:AB_2910400
Visit annotations in context

Tags

RRID:AB_2910400

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2589004225019418
Aug 2025
www.sciencedirect.com www.sciencedirect.com

Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer

1
1. scibot 15 Aug 2025
  
  in Public
  
  RRID:AB_2910400
  
  DOI: 10.1016/j.ccell.2025.07.013
  
  Resource: None
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2910400
  
  What is this?
  
  RRID:AB_2910400
Visit annotations in context

Tags

RRID:AB_2910400

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610825003198